|
|
|
|
Today HIV/AIDS is a global concern. In our “Fight Against AIDS” we have developed a range of antiretroviral medicines which includes two drug and three drug fixed dose combinations formulated at Emcure’s R&D.
Emcure’s efforts have been appreciated by Medical Fraternity, Health Ministries and various NGOs.
|
|
|
Emcure part of the US Govt drive to find better HIV treatments for children
 Mr. Satish Mehta - CEO & Managing Director, Mr. A K Khanna - Executive Director and Mr. Nilesh Patel - Vice President, Emcure-USA, were privileged to be invited to a function at the White House by the First Lady of United States, Ms. Laura Bush, where she announced a new public-private partnership to promote scientific and technical discussions on solutions for pediatric HIV treatment, formulations and access. Emcure is honoured to be a part of this collaboration which includes renowned innovator pharmaceutical companies, generic pharmaceutical companies, multilateral organizations such as UNAIDS and UNICEF and the US Government.
The initiative forms part of the US President’s Emergency Plan for AIDS Relief (PEPFAR), and will work to identify scientific obstacles to treatment for children and take practical steps to address key barriers.
Emcure CEO & Managing Director - Mr. Satish Mehta and Executive Director - Mr. A. K. Khanna with First Lady of United States - Ms. Laura Bush at the White House on 13th March 2006
|
|
Emcure enters into a strategic alliance with Bristol-Myers Squibb
Emcure Pharmaceuticals Ltd. has entered into a strategic alliance with Bristol-Myers Squibb as a part of latter’s global access program. Under the agreement, Emcure would manufacture the bulk drug, finished atazanavir and also market it in Sub-Saharan Africa and India.
Mr. Satish Mehta - CEO & Managing Director, Emcure Pharmaceuticals Ltd. and Mr. Lamberto Andreotti - President Pharmaceuticals, BMS, signed the agreement on 15th February 2006 at BMS Head Quarters, USA.
|
|
Emcure sets up Centre for HIV/AIDS - ‘Taal’ in Pune
Emcure Pharmaceuticals Ltd. in association with Human Resource Development Network (HRDN) and Network of Positive People (NMP+ / INP+) inaugurates ‘TAAL’ – an exclusive pharmacy to provide care and support to people living with HIV/AIDS. Run by HIV positive people, TAAL provides uninhibited access to Treatment, HIV Medication at low cost and Counseling.
From left: Mr. Manoj Pardesi, President of NMP+, Mr.A.K.Khanna - Executive Director, Emcure Pharmaceuticals Ltd., Mr.Nana Patekar, renowned Indian film personality and Mr.Chandu Borde at the inauguration of TAAL on 23rd January 2006.
|
|
|
|
|
